Current screening, design, and delivery approaches to address low permeability of chemically synthesized modalities in drug discovery and early clinical development.
Drug Discov Today
; 28(9): 103685, 2023 09.
Article
de En
| MEDLINE
| ID: mdl-37356613
ABSTRACT
A drug's permeability across biological membranes is a key property associated with the successful development of an orally absorbed drug candidate. Although a variety of methods are available for predicting and assessing permeability, some are more preferred than others at specific stages of drug discovery and development across the pharmaceutical industry. Permeability measurements may be interpreted differently depending on the chosen method. Herein, we present a refreshed perspective on the screening approaches and philosophy in permeability evaluation, from early drug discovery to early clinical development. Additionally, we review and discuss chemical design and drug delivery technologies that can be leveraged to overcome permeability challenges, which are increasingly being used with emerging modalities.
Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Systèmes de délivrance de médicaments
/
Découverte de médicament
Type d'étude:
Diagnostic_studies
/
Screening_studies
Langue:
En
Journal:
Drug Discov Today
Sujet du journal:
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Année:
2023
Type de document:
Article